汽车产业的繁荣带动了上下游产业链协同发展。钢铁、有色金属等原材料行业受益于稳定需求，一季度 钢铁产量同比增长9.2%，电解铝产能利用率提升至92%。汽车金融领域呈现创新态势，截至4月末汽车 消费贷款余额突破5万亿元，其中新能源汽车贷款占比达45%。维修保养市场同样快速增长，头部企业 通过数字化改造将服务效率提升30%。二手车交易市场活跃度显著提高，2025年前4个月交易量同比增 长18%，带动汽车金融、保险等衍生服务规模扩大。 当前全球汽车产业面临复杂挑战。欧美市场对中国新能源汽车发起的反补贴调查已涉及120亿美元规 模，芯片短缺、原材料价格波动等风险犹存。为应对这些挑战，中国车企正通过供应链多元化、海外建 厂等方式降低风险。比亚迪在泰国建成的首个海外工厂将于2025年三季度投产，规划年产能15万辆；上 汽集团在印尼的电池生产基地已进入试生产阶段。这种全球化布局既是对抗贸易壁垒的主动选择，也是 构建双循环发展格局的必然要求。 中国汽车产业的崛起深刻改变了全球产业格局。1980年中国汽车年产量仅为37万辆，2025年前4个月单 季产量已突破千万辆，相当于1980年全年的27倍。这种跨越式发展背后，是改革开放以来 ...

一名失去四肢的受试者，经过一个多月训练，凭借意念操作电脑，流畅进行赛车、下棋等游戏，光标操 控水平逐渐接近普通人使用触摸板的状态，且仍在持续进步……上海阶梯医疗科技有限公司（以下简 称"阶梯医疗"）日前在一场媒体沟通会上展示了一段视频，受试者正通过脑机接口设备用意念玩"马里 奥赛车"游戏。 专家表示，这次临床试验的成果将加快我国后续正式的注册临床试验的进度，使得产品可以更快地注册 取证，让国产脑机接口向着落地走出一大步。 中国首家 全球第二家 华西医院智能可穿戴健康系统研究室主任江宁表示，通过人工智能的方法，让脑机接口的使用门槛越来 越低，希望能够逐渐地把它的渗透率提高，最后能够进入到每个需要有脑机接口服务的家庭。 今年我国脑机接口市场或突破38亿元 据了解，此次试验的受试者因高压电击事故失去四肢。今年3月，在复旦大学附属华山医院，该受试者 接受了由阶梯医疗开发的脑机接口产品植入手术。这是国内首例侵入式脑机接口系统前瞻性临床试验， 让阶梯医疗成为全球继马斯克的Neuralink之后的第二家进入临床阶段的侵入式脑机接口公司。 据阶梯医疗介绍，手术中，两根头发丝百分之一粗细的柔性电极，经微创手术被埋入其大脑，并连 ...

（原标题：年报"难产" *ST恒立状告会计师事务所索赔超3800万元） 近日，*ST恒立（000622.SZ）发布公告称，公司收到法院《受理案件通知书》，公司诉深圳旭泰会计 师事务所（普通合伙）（下称"旭泰会所"）、谭旭明、尹擎、凌辉、王平平侵权责任纠纷一案的起诉状 岳阳楼区法院已收到并决定受理。 其中，谭旭明为旭泰会所执行事务合伙人及项目签字注册会计师，尹擎为项目签字注册会计师，凌辉为 风险管理审核经理，王平平为现场负责人。 *ST恒立认为，旭泰会所作为公司2024年度审计机构，未按约定时间、流程及法定程序开展审计工作， 导致公司无法在法定期限内披露年报，2025年4月30日当日公司市值损失超3800万元。*ST恒立请求判 令旭泰会所赔偿经济损失。 年报"难产" *ST恒立4月23日发布的公告显示，原计划于2025年4月28日披露《2024年年度报告》和《2025年第一季 度报告》，延期至2025年4月30日。但至今相关报告仍未披露。 2024年12月30日，*ST恒立发布《关于改聘会计师事务所的公告》，因原本聘任的会计师事务所自身现 阶段业务繁忙，人员配备不足，无法承接更多业务，而公司年审工作时间紧迫，基 ...

Core Perspective - Annika Yi's artistic practice merges technology and biology, challenging traditional boundaries of visual art and exploring the fragile yet resilient relationships among all forms of life [1][2] Group 1: Artistic Approach - Yi incorporates sensory dimensions such as touch, taste, and smell into her work, prompting audiences to reconsider humanity's position within the interconnected ecosystem [1] - Her art questions human-centric views by integrating non-human entities like mechanical devices, fungi, and algae, leading to reflections on subjectivity and control in the creative process [1] Group 2: Thematic Exploration - The exhibition features nearly 40 selected works designed to evoke a sterile, futuristic atmosphere reminiscent of laboratories or spacecraft, highlighting themes of loss and separation [2] - Yi's works delve into societal obsessions with cleanliness and pollution, using the transient nature of her art to enhance psychological tension among viewers [2] - The exploration of bacterial growth and pathogen invasion serves as a metaphor for societal change and individual transformation, suggesting a dynamic relationship influenced by advancements in artificial intelligence [2]

Core Insights - Puma demonstrates strategic resilience amid management turmoil and global trade uncertainties, maintaining its performance guidance for the fiscal year 2025 despite profit pressures [1][2] Financial Performance - For Q1 of fiscal year 2025, Puma reported revenue of €2.07 billion, a slight increase of 0.1% year-on-year after currency adjustments, while EBIT narrowed to €57.7 million [1] - The company maintains its full-year revenue growth guidance in the single digits and EBIT guidance of €520 million to €600 million [1] Regional Performance - The Asia-Pacific region experienced the largest decline, with sales dropping by 4.7% to €430.5 million, attributed to a 17.7% decrease in the Greater China market [1] - EMEA (Europe, Middle East, and Africa) emerged as a performance anchor with a 5.1% growth, contributing €890 million in revenue [1] - The Americas market saw a 2.7% decline due to weak demand in North America, although Latin America offset this with a 13.1% growth [1] Product Highlights - The Speedcat series, which merges sports and fashion design, has gained market attention, particularly in Asia, with expected sales to exceed 4 million pairs within the year [1] Supply Chain and Management Changes - Puma exhibits supply chain agility in response to potential U.S. tariff policies, with approximately 10% of North American products sourced from China, while strategic production in Vietnam, Cambodia, and Indonesia mitigates risks [2] - The company has delayed the impact of tariffs to Q3 through advance inventory procurement and initiated the "nextlevel" efficiency plan, which includes optimizing 500 headquarters positions and closing 30 underperforming stores [2] - The new CEO, Arthur Hald, will start in July, potentially bringing new operational momentum to Puma [2]

Core Insights - The article discusses the historical significance and evolution of ultramarine, a vibrant blue pigment derived from lapis lazuli, highlighting its journey from a rare luxury to a widely used color in art and industry [1][2] Group 1: Historical Context - Ultramarine originated from lapis lazuli, primarily sourced from Afghanistan and Pakistan, with Afghan lapis being renowned for its quality [1] - In Europe, during the Middle Ages to the Renaissance, ultramarine symbolized holiness and nobility, often used in depictions of the Virgin Mary by masters like Giovanni Bellini, Da Vinci, and Raphael [1] - The pigment was extremely expensive, comparable to gold, leading to delays in artworks due to supply issues, as seen with Michelangelo [1] Group 2: Cultural Significance - In ancient China, lapis lazuli traveled along the Silk Road and was cherished by emperors, being used in Buddhist temples and referred to as "Buddha blue" [2] - Notable Chinese artworks, such as the murals in Dunhuang and Wang Ximeng's "A Thousand Li of Rivers and Mountains," prominently featured ultramarine, adding a sense of mystery and solemnity [2] Group 3: Technological Advancements - The invention of synthetic ultramarine in the 19th century revolutionized the pigment's availability, making it affordable and widely used across various fields, including painting and coatings [2] - This transition from a rare treasure to a common color reflects the intersection of art, history, and technology, showcasing humanity's relentless pursuit of beauty [2]

（原标题：《梵高：画语人生》：走进艺术大师的灵魂世界） 《梵高：画语人生》（ Vincent Van Gogh: Painted with Words ） 赵昭/文 《梵高：画语人生》是一部由安德鲁?哈顿执导的别具一格的电影，它以独特的视角和表现手 法，为观众呈现了荷兰后印象派画家梵高绚烂而又短暂的一生。 影片采用了戏剧式纪录电影的形式，通过演员的精彩演绎和梵高写给亲人信件中的话语，生动地重现了 梵高的人生轨迹。这种叙事方式，让观众仿佛置身于梵高的生活之中，亲身感受他的喜怒哀乐、挣扎与 追求。从梵高早期对宗教的狂热，到后来在弟弟提奥的鼓励下投身绘画，再到他在艺术道路上的探索、 与高更的交往以及最终的悲剧结局，影片都进行了细致入微的刻画。 类型 : 纪录片 / 传记 这部电影不仅仅是对梵高生平的简单记录，更是对他艺术精神的深入挖掘。梵高一生都在孤独中追求自 己的艺术理想，尽管他的作品在生前并未得到广泛认可，但他始终坚持自我，用绘画表达自己对世界的 独特见解。电影通过对他人生经历的展现，让观众明白了他的艺术创作与他的生活经历、情感世界息息 相关。他对劳动人民的同情和怜悯，对爱情的渴望与失望，对孤独的感受与抗争，都 ...

Core Insights - Eli Lilly's tirzepatide has outperformed semaglutide in weight loss effectiveness based on the detailed results of the SURMOUNT-5 head-to-head clinical trial [2][3] Group 1: Study Overview - The SURMOUNT-5 trial is a multicenter, randomized, open-label Phase 3b study aimed at evaluating the efficacy and safety of tirzepatide compared to semaglutide in overweight adults with at least one comorbidity [2] - The trial included approximately 751 participants from the U.S. and Puerto Rico, randomized in a 1:1 ratio to receive either tirzepatide or semaglutide [3] Group 2: Weight Loss Results - At week 72, tirzepatide achieved an average weight reduction of 20.2%, while semaglutide achieved 13.7% [3] - Participants in the tirzepatide group lost an average of 22.8 kg, compared to 15.0 kg in the semaglutide group [3] - The proportion of participants achieving a weight loss of at least 15% was 64.6% for tirzepatide versus 40.1% for semaglutide [3] - Average waist circumference reduction was 18.4 cm for tirzepatide and 13.0 cm for semaglutide [3] Group 3: Safety Profile - The most common adverse events reported during the trial were mild to moderate gastrointestinal issues [4] - The discontinuation rate due to adverse events was 6.1% for the tirzepatide group and 8.0% for the semaglutide group [5]

Core Viewpoint - Wuxi Yelong Precision Machinery Co., Ltd. has voluntarily withdrawn its IPO application after a two-year process, highlighting the survival challenges faced by traditional auto parts suppliers amid the shift towards new energy vehicles [1][2]. Group 1: Company Overview - Yelong is a leading manufacturer of turbocharger housings, claiming the highest global market share in this segment [1]. - The company derives 95% of its revenue from turbocharger products, primarily serving major clients like Garrett and BorgWarner, which are key players in the traditional fuel vehicle market [2]. Group 2: Financial Performance - In Q1 2024, Yelong's revenue declined by 3.52% year-on-year, and its net profit fell by 4.52%, with the capacity utilization rate for its core turbocharger housing dropping to 72.31% [1]. - The company's revenue for 2022 was 1.103 billion yuan, a decrease of 3.5% compared to 2020, and its net profit has remained around 100 million yuan for three consecutive years, with gross margin decreasing from 22.73% to 18.10% [2]. Group 3: Industry Challenges - The penetration rate of new energy vehicles in China exceeded 45% in Q1 2024, leading to a decline in demand for turbochargers as hybrid models increasingly replace traditional fuel vehicles [2]. - Yelong's attempts to pivot towards new energy vehicle components have been insufficient, with new product revenue accounting for less than 5%, facing competition from leading die-casting companies [2]. Group 4: Regulatory and Governance Issues - The company faced scrutiny over its internal controls, including a history of financial misconduct involving 857 million yuan through a subsidiary and improper handling of employee payments [2]. - Governance concerns were raised regarding the lack of industry experience among the controlling shareholders, who were very young and had limited management backgrounds [3]. Group 5: Market Implications - The failure of Yelong's IPO reflects a shift in regulatory scrutiny during the deepening of the registration system, with repeated inquiries about the company's alignment with the main board's positioning and its growth potential [3]. - The IPO approval rate for traditional fuel vehicle parts suppliers was only 33% in Q1 2024, significantly lower than that of new energy supply chain companies, indicating a growing market divide [3].

Core Viewpoint - Guangzhou Ruili Kemi's IPO faces scrutiny due to performance volatility, reliance on related transactions, and internal control risks, despite its leading position in the commercial vehicle active safety system market [1][5]. Group 1: Financial Performance - The company's financial performance is closely tied to the commercial vehicle industry cycle, with a significant profit drop in 2022 due to a 31% decline in commercial vehicle sales, resulting in a net profit decrease from 197 million to 96.96 million [2]. - In 2023, the net profit rebounded to 269 million, but the first half of 2024 saw a 4.52% decline in non-recurring net profit [2]. - Accounts receivable consistently exceed 70% of revenue, with a year-end balance of 566 million in 2023, and a customer concentration of nearly 30% among the top five clients, raising concerns about cash flow pressure [2]. Group 2: Related Transactions - The complex network of related transactions raises concerns, as the controlling shareholder, Ruili Group, is both the largest customer (27.8% of sales in 2021) and a key supplier (12.75% of purchases) [3]. - The company acquired four subsidiaries from Ruili Group for 938 million, with one subsidiary showing a 152% appraisal increase despite reporting a net loss of 2.13 million in 2023 [3]. - A subsidiary was involved in a fraudulent loan scheme, highlighting potential risks of related party fund occupation [3]. Group 3: Internal Control Issues - Systemic internal control vulnerabilities are evident, with a subsidiary using personal accounts for public fund transactions, involving 1.9 million in 2020 [4]. - The company faced fines totaling nearly 300,000 for environmental and safety issues, with a subsidiary penalized for not having waste gas treatment facilities, risking its high-tech enterprise qualification [4]. - Employee rights issues were raised, with 709 employees lacking social insurance and 1,122 without housing fund contributions until just before the IPO application [4]. Group 4: Market and Regulatory Environment - The company plans to raise 1.522 billion for R&D and working capital, but the necessity of expansion is questioned given a 72.77% capacity utilization rate in 2023 and a projected 5.1% decline in commercial vehicle sales in 2024 [4]. - The Shenzhen Stock Exchange has raised concerns about the fairness of related transactions and the adequacy of disclosures regarding the controlling shareholder's historical issues [4]. - The IPO case reflects the regulatory challenges during the deepening of the registration system, balancing technical strength and market share against historical flaws and internal control issues [5].